Patch-Testing for the Management of Hypersensitivity Reactions to Second-Line Anti-Tuberculosis Drugs: A Case Report
Name:
Khan et al - 2014 - Patch-testing ...
Size:
44.58Kb
Format:
PDF
Description:
Main Article
Journal
BMC Research NotesAbstract
The second-line anti-tuberculosis drugs used in the treatment of multidrug-resistant tuberculosis often cause adverse events, especially in patients co-infected with the human immunodeficiency virus. Severe hypersensitivity reactions due to these drugs are rare and there is little published experience to guide their management.Publisher
BioMed Central (Springer Science)PubMed ID
25128289Language
enISSN
1756-0500ae974a485f413a2113503eed53cd6c53
10.1186/1756-0500-7-537